Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Oxidative Stress in Cancer Cell Metabolism
Saniya Arfin, Niraj Kumar Jha, Saurabh Kumar Jha, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 642-642
Open Access | Times Cited: 431
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112563-112563
Open Access | Times Cited: 213
Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 145
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 133
Anti-Inflammatory and Anticancer Effects of Microalgal Carotenoids
Javier Ávila‐Román, Sara García-Gil, Azahara Rodríguez-Luna, et al.
Marine Drugs (2021) Vol. 19, Iss. 10, pp. 531-531
Open Access | Times Cited: 103
Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 102
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 92
Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 66
The structure and function of YTHDF epitranscriptomic m6A readers
Vilbert Sikorski, Simona Selberg, Maciej Łałowski, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 335-353
Open Access | Times Cited: 53
Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects
Seyed Hossein Shahcheraghi, Fateme Salemi, Shlomo Small, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1590-1605
Open Access | Times Cited: 51
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 98
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 91
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Molecular mechanisms of oxidative stress in stroke and cancer
Vishal Chavda, Bipin Chaurasia, Kanwaljeet Garg, et al.
Brain Disorders (2021) Vol. 5, pp. 100029-100029
Open Access | Times Cited: 60
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 48
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Life Sciences (2022) Vol. 300, pp. 120561-120561
Closed Access | Times Cited: 45
Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway
Shih‐Hao Wang, Kun‐Ling Tsai, Wan‐Ching Chou, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 05, pp. 1281-1298
Closed Access | Times Cited: 40
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer
Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3037-3037
Open Access | Times Cited: 37
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer
Giovanni Tossetta, Sonia Fantone, Daniela Marzioni, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 7
Open Access | Times Cited: 37
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 31
The crosstalk between Nrf2 and NF-κB pathways in coronary artery disease: Can it be regulated by SIRT6?
Eman Casper
Life Sciences (2023) Vol. 330, pp. 122007-122007
Closed Access | Times Cited: 30
The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top